Biotech

OncoSec Medical Inc (NASDAQ:ONCS) shares advanced 5.04% on Monday to $1.46 but retreated 0.68% to $1.45 in after-hours trading. Share prices have been trading in a 52-week range of $1.03 to $3.49. The company has a market cap of $28.20 at 19.73 million shares outstanding. OncoSec Medical Inc is a biotechnology...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Intellia Therapeutics Inc. (NASDAQ:NTLA) reported that Caribou Biosciences, Inc. has picked up 5,593,846 of common stock as of 2017-02-28. The acquisition brings the aggregate amount owned by Caribou Biosciences, Inc. to a total of 5,593,846 ...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Amyris Inc. (NASDAQ:AMRS) reported that Temasek Holdings (private) Ltd. has picked up 61,764,891 of common stock as of 2017-02-27. The acquisition brings the aggregate amount owned by Temasek Holdings (private) Ltd. to a total of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) reported that Tang Capital Partners Lp. has picked up 559,900 of common stock as of 2017-02-27. The acquisition brings the aggregate amount owned by Tang Capital Partners Lp. to a total...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Miragen Therapeutics Inc. (NASDAQ:MGEN) reported that Boulder Ventures V, L.p. has picked up 1,607,437 of common stock as of 2017-02-24. The acquisition brings the aggregate amount owned by Boulder Ventures V, L.p. to a total...